Cite
HARVARD Citation
Kischel, R. et al. (n.d.). Preclinical characterization of an EGFRvIII/CD3 specific BiTE® antibody construct for the treatment of glioblastoma multiforme. European journal of cancer. pp. S96-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kischel, R. et al. (n.d.). Preclinical characterization of an EGFRvIII/CD3 specific BiTE® antibody construct for the treatment of glioblastoma multiforme. European journal of cancer. pp. S96-. [Online].